4.4 Article

Role of microRNAs in myeloid differentiation

期刊

BIOCHEMICAL SOCIETY TRANSACTIONS
卷 36, 期 -, 页码 1201-1205

出版社

PORTLAND PRESS LTD
DOI: 10.1042/BST0361201

关键词

acute myeloid leukaemia (AML); all-trans retinoic acid (ATRA); CCAAT/enhancer-binding protein (C/EBP); haemopoiesis; microRNA (miRNA); myelopoiesis

资金

  1. AIRC (Associazione Italiana per la Ricerca sul Cancro) and AIRC-ROC (Rome Oncogenic Centre)
  2. Sixth Research Framework Programme of the European Union
  3. Project RIGHT (RNA Interference Technology as Human Therapeutic Tool) [LSHB-CT-2004 005276]
  4. SIROCCO (Silencing RNAs: Organisers and Coordinators of Complexity in Eukaryotic Organisms) [037900]
  5. PRIN (Progetti di Ricerca di Interesse Nazionale)

向作者/读者索取更多资源

All types of blood cell of the body are continuously produced by rare pluripotent self-renewing HSCs (haemopoietic stem cells) by a process known as haemopoiesis. This process provides a valuable model for examining how genetic programmes involved in cell differentiation are established, and also how cell-fate specification is altered in leukaemia. Here, we describe examples of how miRNAs (microRNAs) can influence myelopoiesis and how the identification of their target mRNAs has contributed to the understanding of the molecular networks involved in the alternative control between cell growth and differentiation. Ectopic expression and knockdown of specific miRNAs have provided powerful molecular tools able to control the switch between proliferation and differentiation, therefore providing new therapeutic tools for interfering with tumorigenesis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据